Randomized immunotherapy trial in dual-allergic patients using "active allergen placebo" as control.

Martin Wagenmann Margitta WormYasemin AkbogaMartin KarjalainenJens M Hohlfeld

Published in: Allergy (2019)

Immunotherapies for both grass and birch allergens were efficacious and safe. The study confirms the specificity of AIT. Untargeted treatment groups could serve as controls in future AIT trials.

Keyphrases

phase iii
end stage renal disease
double blind
ejection fraction
chronic kidney disease
newly diagnosed
open label
clinical trial
phase ii
placebo controlled
mass spectrometry
prognostic factors
randomized controlled trial
patient reported outcomes
high resolution
current status
patient reported
smoking cessation